LV Thrombus Pilot Study for Comparing Enoxaparin Vs. Warfarin
Status:
Completed
Trial end date:
2004-04-01
Target enrollment:
Participant gender:
Summary
To prospectively evaluate the utility of enoxaparin vs. oral warfarin in reduction of
echocardiographic indices of LV mural thrombus. The primary outcome is the presence of LV
mural thrombus at 3.5 months. The secondary outcome is cost analysis comparing the two arms.